Its genetic deletion accelerates atherosclerosis and is associated with elevated plasma levels of CCL5, an expansion of the platelet count, increase in MPV, and elevation of activation markers such as P-selectin, and leukocyte-platelet complexes (Murphy et al., 2014). Here, CCL5 is linked to atherosclerosis.